Chapter 3. Nuclear Receptor-Mediated Regulation of Phase II Conjugating Enzymes

  1. Wen Xie2,3
  1. Oliver Barbier

Published Online: 14 MAY 2008

DOI: 10.1002/9780470409107.ch3

Nuclear Receptors in Drug Metabolism

Nuclear Receptors in Drug Metabolism

How to Cite

Barbier, O. (2008) Nuclear Receptor-Mediated Regulation of Phase II Conjugating Enzymes, in Nuclear Receptors in Drug Metabolism (ed W. Xie), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470409107.ch3

Editor Information

  1. 2

    Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, PA, USA

  2. 3

    Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA

Author Information

  1. Faculty of Pharmacy, Laval University and Research Center of the “Centre Hospitalier de l'Université Laval—CRCHUL”, Québec, Canada

Publication History

  1. Published Online: 14 MAY 2008
  2. Published Print: 24 OCT 2008

ISBN Information

Print ISBN: 9780470086797

Online ISBN: 9780470409107

SEARCH

Keywords:

  • phase I nuclear receptor-mediated regulation;
  • CAR and PXR xenosensors;
  • PPARs and PHASE II XMEs regulation

Summary

This chapter contains sections titled:

  • Introduction

  • Phase II Drug Metabolizing Enzymes

  • The Xenosensors CAR and PXR: Two Master Regulators of Phase II Metabolism

  • AhR and Nrf2, Two Important Regulators of Phase II Enzymes

  • PPARs and Phase II XMEs Regulation

  • FXR/LXRα and Phase II XMEs Regulation

  • HNF and Phase II XMEs Regulation

  • Regulation of Phase II Conjugating Enzymes by Steroid and Thyroid Receptors

  • Concluding Remarks and Perspectives

  • References